These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18998268)

  • 41. Sexual dysfunction in chronic renal failure.
    Bellinghieri G; Santoro D; Mallamace A; Savica V
    J Nephrol; 2008; 21 Suppl 13():S113-7. PubMed ID: 18446743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): a possible new marker of systemic endothelial dysfunction?
    Sánchez-Villanueva R; Bajo A; Del Peso G; Fernandez-Reyes MJ; González E; Romero S; Estrada P; Selgas R
    Nephrol Dial Transplant; 2009 Mar; 24(3):1009-14. PubMed ID: 18997161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of renal dysfunction as a cardiovascular risk factor.
    Adamczak M; Ritz E
    Rocz Akad Med Bialymst; 2005; 50():50-3. PubMed ID: 16358939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genesis of the uraemic syndrome: role of uraemic toxins.
    Hörl WH
    Wien Klin Wochenschr; 1998 Aug; 110(15):511-20. PubMed ID: 9782569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patients.
    Vonend O; Rump LC; Ritz E
    Semin Dial; 2008; 21(4):326-30. PubMed ID: 18627567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ageing endothelium, cardiovascular risk and disease in man.
    Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S
    Exp Physiol; 2009 Mar; 94(3):317-21. PubMed ID: 18805864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Glomerular filtration rate is an indicator of endothelial function at early stages of chronic kidney disease].
    Smirnov AV; Petrishchev NN; Panina IIu; Rumiantsev ASh; Degtereva OA; Tugusheva FA; Menshutina MA
    Ter Arkh; 2007; 79(6):25-30. PubMed ID: 17684962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Primary prevention of cardiovascular disease].
    Katić T; Sakić I; Bergovec M
    Acta Med Croatica; 2009 Feb; 63(1):71-4. PubMed ID: 19681467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes and cardiovascular disease: explaining the relationship.
    Punthakee Z; Werstuck GH; Gerstein HC
    Rev Cardiovasc Med; 2007; 8(3):145-53. PubMed ID: 17938614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.
    Ninomiya T; Kiyohara Y; Tokuda Y; Doi Y; Arima H; Harada A; Ohashi Y; Ueshima H;
    Circulation; 2008 Dec; 118(25):2694-701. PubMed ID: 19106392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Renal failure stages as predictors of mortality following acute coronary syndrome].
    Sanchez Hidalgo A; Pou M; Leiro R; López Gómez D; Martínez Ruiz M; Saurina A; Esteve V; Fulquet M; Ramírez de Arellano M; de Miguel M
    Nefrologia; 2009; 29(1):53-60. PubMed ID: 19240772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hypertension, endothelial dysfunction and cardiovascular risk].
    Nitenberg A
    Arch Mal Coeur Vaiss; 2006 Oct; 99(10):915-21. PubMed ID: 17100143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is early chronic kidney disease an important risk factor for cardiovascular disease? A background paper prepared for the UK Consensus Conference on early chronic kidney disease.
    Daly C
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 9():ix19-25. PubMed ID: 17998227
    [No Abstract]   [Full Text] [Related]  

  • 60. [A major vascular risk factor: mild impairment of renal function].
    Tepel M
    MMW Fortschr Med; 2003 Apr; 145(15):51-2. PubMed ID: 15104267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.